Medication Use in Early-HD Participants in Track-HD: an Investigation of its Effects on Clinical Performance.

PLoS Currents
Ruth KeoghS J Tabrizi

Abstract

 Insufficient evidence exists to guide the long-term pharmacological management of Huntington's disease (HD) although most current interventions rely on symptomatic management. The effect of many frontline treatments on potential endpoints for HD clinical trials remains unknown. Our objective was to investigate how therapies widely used to manage HD affect the symptom for which they are prescribed and other endpoints using data from TRACK-HD. We used longitudinal models to estimate effects of medication use on performance on tests of motor, cognitive and neuropsychiatric function using data from 123 TRACK-HD stage 1/2 participants across four study visits. Adjustment for confounding by prior medication use, prior clinical performance, concomitant use of other medications, and baseline variables (sex, disease group, age, CAG, study site, education) enabled a closer-to-causal interpretation of the associations. Adjusting for baseline variables only, medication use was typically associated with worse clinical performance, reflecting greater medication use in more advanced patients. After additional adjustment for longitudinal confounders such "inverse" associations were generally eliminated and in the expected directions: particip...Continue Reading

Citations


❮ Previous
Next ❯

Software Mentioned

mice
HD
TRACK

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
Catherine A SumidaMaureen Schmitter-Edgecombe
Lancet Neurology
Karl Kieburtz, Charles Venuto
Movement Disorders : Official Journal of the Movement Disorder Society
Cristina SampaioR Reilmann
© 2021 Meta ULC. All rights reserved